Callan Family Office’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
21,453
-2,568
-11% -$361K 0.06% 285
2026
Q1
$3.15M Sell
24,021
-1,579
-6% -$227K 0.07% 263
2025
Q4
$3.4M Buy
25,600
+10,968
+75% +$1.46M 0.07% 245
2025
Q3
$1.92M Sell
14,632
-1,701
-10% -$232K 0.06% 273
2025
Q2
$2.18M Buy
16,333
+9,333
+133% +$1.07M 0.07% 262
2025
Q1
$767K Sell
7,000
-1,549
-18% -$187K 0.06% 247
2024
Q4
$1.06M Buy
8,549
+5,092
+147% +$618K 0.07% 241
2024
Q3
$378K Buy
3,457
+666
+24% +$71.7K 0.06% 122
2024
Q2
$307K Buy
2,791
+291
+12% +$32.2K 0.06% 117
2024
Q1
$284K Sell
2,500
-29
-1% -$2.98K 0.07% 79
2023
Q4
$246K Sell
2,529
-187
-7% -$17.1K 0.06% 89
2023
Q3
$262K Sell
2,716
-1,339
-33% -$128K 0.07% 77
2023
Q2
$367K Sell
4,055
-45
-1% -$3.79K 0.1% 77
2023
Q1
$357K Buy
4,100
+45
+1% +$3.93K 0.09% 120
2022
Q4
$390K Buy
+4,055
New +$365K 0.13% 67

Other funds holding EMR

Callan Family Office's EMR Position: Q2 2026 in Review

Callan Family Office reduced its Emerson Electric (EMR) stake by 11% in Q2 2026, selling an estimated $361K and leaving 21,453 shares worth $3.07M. The position accounts for 0.06% of the portfolio, ranked #285.

Callan Family Office first reported a position in EMR in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.4M in Q4 2025. 2,297 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • Callan Family Office held 21,453 shares of Emerson Electric worth $3.07M as of Q2 2026.
  • Callan Family Office sold 2,568 Emerson Electric shares in Q2 2026, an estimated $361K.
  • Emerson Electric made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #285 holding.
  • Callan Family Office first reported a position in Emerson Electric in Q4 2022 and has held it in 15 quarters since.
  • Callan Family Office's Emerson Electric position peaked at $3.4M in Q4 2025.
  • 2,297 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.